Fast Moving Stocks: Blueprint Medicines Corporation (NASDAQ:BPMC), Immune Design Corp.

Blueprint Medicines Corporation (NASDAQ:BPMC) had its target price reduced by Goldman Sachs from $26.00 to $15.00 in a research note released on Monday morning, StockTargetPrices.com reports.

Blueprint Medicines Corporation (NASDAQ:BPMC) belongs to Healthcare sector. Its weekly performance is 2.68%. On last trading day company shares ended up at $17.27. Blueprint Medicines Corporation (NASDAQ:BPMC) distance from 50-day simple moving average (SMA50) is -5.68%.

On 9 February, Immune Design Corp. (NASDAQ:IMDZ) reported positive topline data from three ongoing Phase 1 oncology studies that support continued development of its two primary in vivo immuno-oncology product candidates, CMB305 and G100.

Immune Design Corp. (NASDAQ:IMDZ) shares moved down -6.73% in last trading session and ended the day at $9.43. IMDZ Gross Margin is 90.20% and its return on assets is -40.50%. Immune Design Corp. (NASDAQ:IMDZ) quarterly performance is -49.38%.

On 10 February, CTI BioPharma Corp. (NASDAQ:CTIC) provided an update regarding the clinical studies being conducted under the Company’s Investigational New Drug (“IND”) application for pacritinib.

CTI BioPharma Corp. (NASDAQ:CTIC) belongs to Healthcare sector. Its weekly performance is 63.15%. On last trading day company shares ended up at $0.68. CTI BioPharma Corp. (NASDAQ:CTIC) distance from 50-day simple moving average (SMA50) is 2.68%.

On 12 February, Groupon, Inc. (NASDAQ:GRPN) said that, its 4Q15 results indicate stability, particularly in North America. The region’s local gross billings and gross profits grew 6 percent year on year and 8 percent year on year, respectively, while gross profits in the EMEA declined 14 percent year on year due to lower than expected billings.

Groupon, Inc. (NASDAQ:GRPN) shares moved down -2.09% in last trading session and ended the day at $4.22. GRPN Gross Margin is 44.40% and its return on assets is 1.00%. Groupon, Inc. (NASDAQ:GRPN) quarterly performance is 51.25%.

Koppers Holdings Inc. (NYSE:KOP) announced that, it will post its Q415 quarterly earnings results on Thursday, February 25th.

Koppers Holdings Inc. (NYSE:KOP) shares moved down -7.06% in last trading session and ended the day at $16.18. KOP Gross Margin is 15.40% and its return on assets is -1.40%. Koppers Holdings Inc. (NYSE:KOP) quarterly performance is -25.47%.

Leave a Reply

Your email address will not be published. Required fields are marked *